XML 22 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:      
Net income $ 4,593 $ 3,184 $ 905
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Depreciation and amortization 10,766 8,203 6,879
Amortization of deferred loan costs 53 85 60
Noncash interest expense 961 1,215 0
Stock-based compensation expense 5,056 7,052 5,123
Other loss from sale of assets 0 0 22
Foreign currency transaction losses (gains) on short-term intercompany balances 1,002 (2,190) 84
Income taxes (1,321) 731 (861)
Changes in fair value of contingent consideration (1,628) (2,283) 0
Changes in operating assets and liabilities, net of business acquisitions:      
Restricted cash 5 (4) 1
Billed receivables (8,639) (3,949) (3,339)
Unbilled receivables (992) (469) (509)
Prepaid expenses and other current assets 2,404 (417) (1,506)
Other assets (229) (57) (65)
Accounts payable and accrued expenses (3,275) 815 1,218
Accrued payroll and related expenses 778 975 2,606
Refund liabilities (2,112) 115 67
Deferred revenue 1,036 101 (5)
Compensation, Long-term Incentive, Payout (6,378) 0 0
Other long-term liabilities 351 353 (562)
Net cash provided by operating activities 2,431 13,460 10,118
Cash flows from investing activities:      
Business acquisition, net of cash acquired 19 (10,128) (3,669)
Capital expenditures for property, equipment and software, net of disposal proceeds (10,398) (9,355) (5,887)
Net cash used in investing activities (10,379) (19,483) (9,556)
Cash flows from financing activities:      
Repayments of long-term debt (13,500) 66 0
Payment of deferred loan costs (38) (155) 0
Proceeds from credit facility 21,500 10,000 3,600
Business acquisitions, payment of earnout liability (4,000) 0 0
Repurchases of common stock (4,069) 0 (3,772)
Restricted stock repurchased from employees for withholding taxes (1,281) (100) (218)
Proceeds from option exercises 4,422 1,172 326
Net cash provided by (used in) financing activities 3,034 10,983 (64)
Effect of exchange rates on cash and cash equivalents 64 (1,860) 103
Net (decrease) increase in cash and cash equivalents (4,850) 3,100 601
Cash and cash equivalents at beginning of period 18,823 15,723 15,122
Cash and cash equivalents at end of period 13,973 18,823 15,723
Supplemental disclosure of cash flow information:      
Cash paid during the period for interest 681 434 60
Cash paid during the period for income taxes, net of refunds received 3,255 2,929 1,407
Noncash investing activities:      
Fair value of contingent consideration liabilities at the date of acquisition 0 5,954 3,834
Capital expenditures incurred but not yet paid $ 1,954 $ 365 $ 203